Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities:
Net earnings	$ 82	$ 103
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	56	54
Stock-based compensation	10	13
Deferred income taxes	84	(1)
Loss on divestiture	0	112
Other	(12)	(5)
Changes in:
Receivables, net	118	84
Inventories, net	(55)	(6)
Prepaid expenses and other current assets	(41)	(38)
Accounts payable and accrued liabilities	(40)	(137)
Operating lease right-of-use assets and liabilities, net	(2)	0
Income taxes payable / prepaid	(107)	42
Net cash provided by operations	93	221
Investing activities:
Capital expenditures	(36)	(39)
Proceeds from divestiture, net of cash divested	0	128
Other	2	0
Net cash (used for) provided by investing activities	(34)	89
Financing activities:
Notes and loans payable, net	214	0
Treasury stock purchased	(129)	(107)
Cash dividends paid to Clorox stockholders	(151)	(151)
Issuance of common stock for employee stock plans and other	7	21
Net cash used for financing activities	(59)	(237)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1)	2
Net increase (decrease) in cash, cash equivalents and restricted cash	(1)	75
Cash, cash equivalents and restricted cash:
Beginning of period	170	207
End of period	$ 169	$ 282